Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30087143 | 1.00 | METAP2 (0.48) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL8974216 | 0.97 | METAP2 (0.45) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL30337692 | 0.97 | METAP2 (0.45) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL22579291 | 0.88 | ALDH1A1 (0.58) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL29424406 | 0.88 | ALDH1A1 (0.58) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL18573201 | 0.87 | NPC1 (0.49) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL13192068 | 0.87 | KDM1A (0.57) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL9237008 | 0.87 | KDM1A (0.57) | METAP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3173634 | 0.87 | NPC1 (0.53) | METAP2MEN1KMT2AALDH1A1NPC1 | |
| SCHEMBL15614080 | 0.87 | HSD17B10 (0.56) | MEN1KMT2AALDH1A1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113774509-B | Method and device for preparing modified meta-aramid fiber through continuous polymerization-dry-wet spinning | 株洲时代新材料科技股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-114957661-A | Preparation method of display screen cover plate, display screen cover plate and display device | 京东方科技集团股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-108346766-A | A kind of heat-staple lithium ion battery separator and preparation method thereof | 长沙新材料产业研究院有限公司 | 2018-07-31 | — | — | CN | claimed |
| CN-107189436-A | A kind of polyimide nano foam and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-09-22 | — | — | CN | claimed |
| CN-116635365-A | Material for electronic devices | 默克专利有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-110475838-B | Polymer for liquid crystal aligning agent, liquid crystal aligning agent composition comprising same, liquid crystal aligning film using same, and liquid crystal display device | 株式会社LG化学 | 2023-05-26 | — | — | CN | disclosed |
| CN-112898198-B | Nitrogen-containing aromatic heterocyclic nitro compound and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-04-07 | — | — | CN | disclosed |
| CN-110753739-B | Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using the same, and liquid crystal alignment film and liquid crystal display using the same | 株式会社LG化学 | 2023-03-14 | — | — | CN | disclosed |
| CN-110191938-B | Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using the same, and liquid crystal alignment film using the same | 株式会社LG化学 | 2023-03-10 | — | — | CN | disclosed |
| CN-110546238-B | Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using the same, and liquid crystal alignment film using the same | 株式会社LG化学 | 2023-02-21 | — | — | CN | disclosed |
| CN-110546239-B | Copolymer for liquid crystal aligning agent, liquid crystal aligning agent comprising same, and liquid crystal alignment film and liquid crystal display device using same | 株式会社LG化学 | 2023-02-17 | — | — | CN | disclosed |
| CN-110168054-B | Polymer for liquid crystal aligning agent, liquid crystal aligning agent comprising same, and liquid crystal alignment film and liquid crystal display device using same | 株式会社LG化学 | 2023-02-17 | — | — | CN | disclosed |
| WO-2019039791-A1 | POLYMER FOR LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNING AGENT COMPOSITION COMPRISING SAME, AND LIQUID CRYSTAL ALIGNING FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME COMPOSITION | 주식회사 엘지화학 | 2019-02-28 | — | — | WO | disclosed |
| CN-108558770-A | A kind of preparation method of diamino azaaromatics | 中国科学院长春应用化学研究所 | 2018-09-21 | — | — | CN | disclosed |
| CN-108346766-A | A kind of heat-staple lithium ion battery separator and preparation method thereof | 长沙新材料产业研究院有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-107189436-A | A kind of polyimide nano foam and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-09-22 | — | — | CN | disclosed |
| US-6794378-B2 | ANTIINFLAMMATORY AGENTS | AJINOMOTO CO., INC. (JP) | 2004-09-21 | — | — | US | disclosed |
| CN-1372548-A | Heterocyclic compound and medical use thereof | AJINOMOTO KK (JP) | 2002-10-02 | — | — | CN | disclosed |
| US-20020133005-A1 | Heterocyclic compounds and medical use thereof | AJINOMOTO CO., INC. (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-1193255-A1 | HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF | Ajinomoto Co., Inc. (JP) | 2002-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133005-A1 | Heterocyclic compounds and medical use thereof | NFKBIA, CHUK, RELA | METAP2 1266/4885MEN1 3117/4885KMT2A 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.